| 000 | 01921 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515013327.0 | ||
| 264 | 0 | _c20060222 | |
| 008 | 200602s 0 0 eng d | ||
| 022 | _a0019-9567 | ||
| 024 | 7 |
_a10.1128/IAI.74.2.994-1000.2006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcKenzie, Robin | |
| 245 | 0 | 0 |
_aComparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults. _h[electronic resource] |
| 260 |
_bInfection and immunity _cFeb 2006 |
||
| 300 |
_a994-1000 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Bacterial _xanalysis |
| 650 | 0 | 4 | _aAntibody-Producing Cells |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEnterotoxins _xmetabolism |
| 650 | 0 | 4 |
_aEscherichia coli _ximmunology |
| 650 | 0 | 4 |
_aEscherichia coli Infections _xprevention & control |
| 650 | 0 | 4 |
_aEscherichia coli Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aFeces _xmicrobiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin A _xanalysis |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aVaccines, Attenuated _xadministration & dosage |
| 700 | 1 | _aBourgeois, A Louis | |
| 700 | 1 | _aEngstrom, Fayette | |
| 700 | 1 | _aHall, Eric | |
| 700 | 1 | _aChang, H Sunny | |
| 700 | 1 | _aGomes, Joseph G | |
| 700 | 1 | _aKyle, Jennifer L | |
| 700 | 1 | _aCassels, Fred | |
| 700 | 1 | _aTurner, Arthur K | |
| 700 | 1 | _aRandall, Roger | |
| 700 | 1 | _aDarsley, Michael | |
| 700 | 1 | _aLee, Cynthia | |
| 700 | 1 | _aBedford, Philip | |
| 700 | 1 | _aShimko, Janet | |
| 700 | 1 | _aSack, David A | |
| 773 | 0 |
_tInfection and immunity _gvol. 74 _gno. 2 _gp. 994-1000 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/IAI.74.2.994-1000.2006 _zAvailable from publisher's website |
| 999 |
_c16044252 _d16044252 |
||